AP-205™ is being developed as an ‘off-the-shelf’ CAR-engineered NK cell therapy which targets tumors expressing membrane Hsp70. Gene editing will improve persistence, potency and efficacy.
AP-205™ Allogeneic CAR NK Cells
AP-205™ is being developed as an ‘off-the-shelf’ CAR-engineered NK cell therapy which targets tumors expressing membrane Hsp70. Gene editing will improve persistence, potency and efficacy.